Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Genialis Raises $13M in Financing to Build Clinical Biomarkers that Predict Patient Response
Genialis, a computational precision medicine company unraveling complex biology to find new ways to address […]
Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates
Salubris Biotherapeutics, a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, […]
Cora Therapeutics Announces $1M in Seed Funding
Cora Therapeutics, a Toronto-based life sciences start-up, is pleased to announce the company has raised […]
SolasCure Announces Final Closing of £10.9m Series B Fundraise to Advance Wound Care Innovation
SolasCure, a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which […]
Companion Spine Closes $60.1 Million Series A Funding Round
Companion Spine, the French-American specialist in interventional spine pain-management surgery, today announced the successful closing […]
GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare
GT Medical Technologies, a medical device company dedicated to improving the lives of patients with […]
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution
Mindset Health, the digital hypnotherapy company, today announced it has raised US$12 (A$17.8) million in […]
Hackensack Meridian Health Invests $14 Million Into Oncology Expansion at JFK University Medical Center
Hackensack Meridian Health is proud to announce it is investing $14 million dollars at JFK […]
Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform
Seamless Therapeutics today announced a $12.5 million (€11.8M) seed financing round which will accelerate further […]
- Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
- NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
- Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
- Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
- Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more